Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Urethane, also known as ethyl carbamate, is an organic compound with the chemical formula C3H7NO2 (NH2COOC2H5). It appears as odorless colorless crystals or a white powder and is readily soluble in water and alcohol. Urethane has historically been used in medicine as a sedative-hypnotic and anesthetic agent but is now rarely used clinically due to its carcinogenicity. Mechanistically, it acts primarily as a central nervous system depressant. Urethane has also been utilized in biochemical research and veterinary medicine. It is classified as a multisite carcinogen capable of inducing tumors in various animal species[2][5]. In addition to pharmaceutical uses, it serves roles as a solubilizer for pesticides/fumigants and can be found naturally at low levels in some fermented foods[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on urethane.